Researchers have developed an ingestible biosensor pill (PRIM) that detects intestinal inflammation by releasing a blue dye ...

One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and ...

Damodar Dharmananda Kosambi was a towering figure in the field of history-writing in India. His works on various aspects of ...

A new study shows that while decentralized clinical trials (DCTs) are making research more accessible, they also bring ...

Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...

A research team has developed a technology that distinguishes lung cancer gene mutations solely by measuring the "stiffness" ...

Decentralized Clinical Trials (DCTs) are transforming how we collect clinical data, but this evolution brings unprecedented challenges in data quality, complexity, and integration.

The binding of proteins to DNA is crucial for producing other proteins, ensuring that all the necessary processes in cells ...

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often ...

At the CCOI-Stanford Summit, Goldberg calls for collaborative trial models that could redefine efficiency and standardization ...

Procedural flexibility incorporated into many cancer clinical trials during the COVID-19 pandemic had no long-term negative ...

Transparent expectation-setting and addressing potential disappointments can foster safety, reduce anxiety, and promote ...